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Hypertension is common, affecting over one billion people world­
wide, and is responsible for over seven million deaths annually. [1] 
The presence of hypertension increases the risk of myocardial 
infarction, heart failure, renal failure and cerebrovascular disease. [2] 
Importantly, in sub­Saharan Africa hypertensive disease not only 
affects the older population but is becoming increasingly prevalent 
in younger patient groups.[3] In South Africa (SA), >30% of the adult 
population have hypertension,[4] and it remains the single most 
common cardiovascular risk factor and the predominant contributor 
to cardiovascular disease and mortality.[5,6]
Elevated blood pressure is the most common perioperative 
comorbidity encountered in non­cardiac surgical patients, 
with an overall prevalence of 20 ­ 25%,[7] and it remains poorly 
controlled in low­ and middle­income countries.[8,9] Furthermore, 
hypertension in the perioperative setting may adversely affect patient 
outcome. [10] Hypertension therefore poses perioperative challenges to 
anaesthesiologists, while simultaneously identifying patients at risk of 
long­term morbidity and mortality.[11,12]
Hypertension is most frequently diagnosed and treatment 
initiated in the primary healthcare setting. However, in a resource­
limited environment, the perioperative period gives clinicians a 
unique opportunity to identify patients with hypertensive disease, 
educate patients about the disease, and initiate appropriate therapy. 
Furthermore, this period provides the opportunity to refer patients 
for further investigation or follow­up at peripheral healthcare 
centres for ongoing management, thus aiding the decentralisation 
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Background. Hypertension is common, affecting over one billion people worldwide. In sub­Saharan Africa, hypertensive disease not only 
affects the older population but is becoming increasingly prevalent in younger individuals. In South Africa (SA), >30% of the adult population 
has hypertension, making it the single most common cardiovascular risk factor and the predominant contributor to cardiovascular disease 
and mortality. Elevated blood pressure is the most common perioperative comorbidity encountered in non­cardiac surgical patients, with 
an overall prevalence of 20 ­ 25%, and it remains poorly controlled in low­ and middle­income countries. Hypertension in the perioperative 
setting may adversely affect patient outcome. It therefore not only flags possible perioperative challenges to anaesthesiologists, but also 
identifies patients at risk of long­term morbidity and mortality.
Objectives. To determine the prevalence and severity of hypertension in elective adult surgical patients in the Western Cape Province, SA.
Results. The study population included all elective surgical patients from seven hospitals in the Western Cape during a 1­week period. 
Hypertension, defined as having had a previous diagnosis of hypertension or meeting the blood pressure criteria of >140/90 mmHg, was 
identified in 51.8% of patients during preoperative assessment. Significantly, newly diagnosed hypertension was present in 9.9% of all 
patients presenting for elective surgery. Although 98.1% of the known hypertensive patients were on antihypertensive therapy, 36.9% were 
inadequately controlled. There are numerous reasons for this, but notably 32.1% of patients admitted to forgetting to take their medication, 
making patient factors the most common reason for treatment non­compliance.
Conclusions. The perioperative period may be an important opportunity to identify undiagnosed hypertensive patients. The perioperative 
encounter may have a significant public health implication in facilitating appropriate referral and treatment of patients with hypertension 
to decrease long­term cardiovascular complications in SA.
S Afr Med J 2018;108(7):590­595. DOI:10.7196/SAMJ.2018.v108i7.13022
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of chronic, long­term care. The efficient identification and diagnosis 
of hypertension in the perioperative period could therefore be 
seen as an effective utilisation of planned surgical admission by 
simultaneously addressing a primary healthcare need, and this 
may serve as an efficient healthcare strategy in reducing long­term 
cardiovascular morbidity and mortality.[13,14] Identification and/
or optimisation of hypertensive management in the perioperative 
period is an attractive healthcare intervention in a resource­limited 
environment such as SA, particularly when considering difficulties 
with primary healthcare access and treatment compliance.
Objectives
The primary objective of this study was to describe the prevalence and 
severity of hypertension in adult patients presenting for non­cardiac, 
non­obstetric elective surgery in all surgical disciplines at seven 
hospitals in the Western Cape Province, SA, in order to determine 
whether perioperative screening can be used to supplement primary 
healthcare management of hypertension through developing effective 
strategies for the diagnosis and management of hypertension in 
patients presenting for elective surgery. The secondary objectives 
were to identify hypertension­associated target organ damage and 
risk factors associated with hypertension, and to assess compliance 
with prescribed hypertensive therapy.
Methods
This was a multicentre, prospective, observational study conducted 
at seven hospitals in the Western Cape: one tertiary institution, 
Groote Schuur Hospital, and six secondary institutions, George, 
Mitchell’s Plain, New Somerset, Paarl, Victoria and Worcester hospi­
tals. Ethics approval was obtained for all institutions (ref. nos HREC 
661/2016 and 708/2016 and NHRD WC_2016RP55_876), and writ­
ten informed consent was obtained prior to patient enrolment in the 
study. The trial was registered on the South African National Clinical 
Trial Register (NCT03157661).
All adult, non­cardiac, non­obstetric patients admitted the day 
before elective surgery during the study period were eligible for 
inclusion. Exclusion criteria were patient refusal, day­case surgery 
(as no preceding day preoperative assessment was possible) and 
patients not requiring an anaesthetic. Recruitment was from 07h00 
on Monday to 19h00 on Friday of the week chosen for the study.
Data were collected by anaesthesia medical officers, registrars 
and consultants assigned to each of the surgical lists at the various 
institutions. Routine preoperative information was recorded on 
a specifically designed paper case report form and then captured 
onto the Research Electronic Data Capture (REDCap) web­based 
application. Compliance with medical therapy was assessed using 
the Morisky Medication Adherence Questionnaire.[15,16] A positive 
response to two or more of the four questions was considered to 
indicate non­compliance with antihypertensive treatment.
Assessment of preoperative hypertension was evaluated using 
the South African Hypertension Practice Guideline.[2] All blood 
pressure measurements were performed with an appropriately sized 
non­invasive blood pressure cuff, using an automated oscillometric 
method of blood pressure measurement. If the patient was found to 
have a systolic blood pressure of ≥140 mmHg or a diastolic blood 
pressure of ≥90 mmHg, two further measurements were performed 
at least 5 minutes apart. The lowest of the three readings was taken 
as the preoperative blood pressure. Patients who still had a systolic 
blood pressure of ≥140 mmHg or a diastolic blood pressure of 
≥90 mmHg after these three blood pressure readings were considered 
to be hypertensive.[4]
Categorical variables were described as proportions and compared 
using χ2 tests and Fisher’s exact tests, as appropriate. Continuous 
variables were described as means and standard deviations (SDs) or 
medians and interquartile ranges (IQRs) and compared using t­tests 
or one­way analysis of variance, as appropriate. Data were analysed 
using the Statistical Package for the Social Sciences (SPSS) version 24 
(SPSS, USA).
Results
The seven participating hospitals and numbers of patients screened 
and recruited with complete data are shown in Table 1. Patient 
recruitment and the prevalence and control of hypertension are 
shown in Fig. 1. Of the 397 patients who were screened, 5 refused 
to participate and 4 did not meet the inclusion criteria. Six patients 
were excluded from the analysis owing to incomplete datasets. 
Analysis was possible on full datasets of 382/388 consenting patients 
(98.5%).
Of the patients, 160 (41.9%) had previously diagnosed hypertension, 
while newly diagnosed hypertension was present in a further 38 
(9.9%). The prevalence of hypertension, defined as having a previous 
diagnosis of hypertension or meeting the blood pressure criteria 
of >140/90 mmHg, was therefore 198/382 (51.8%, 95% confidence 
interval (CI) 46.8 ­ 56.8) in the preoperative assessment.
The characteristics of the recruited patients are shown in Table 2. 
Hypertensive patients were older, carried more risk factors for 
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Fig. 1. PRISMA diagram depicting the study recruitment process.
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hypertension and had more comorbidities as reflected by the higher 
American Society of Anesthesiologists grading. Hypertensive patients 
had significantly more target organ damage, specifically coronary 
artery disease, heart failure, advanced retinopathy, cerebrovascular 
disease, chronic renal disease, peripheral arterial disease, diabetes 
and dyslipidaemia.
The severity of hypertension is shown in Table 3. Of all the 
hypertensive patients, 99/198 (50.0%, 95% CI 43.0 ­ 57.0) were 
found to have a blood pressure >140/90 mmHg. Despite the vast 
majority of known hypertensive patients (157/160, 98.1%) being on 
antihypertensive therapy preoperatively, blood pressure control was 
inadequate in 61/160 (38.1%, 95% CI 31.2 ­ 46.3).
Table 1. Participating hospitals
Institution Level of care
Patients screened
(N=397), n
Patients recruited with 
complete data (N=382), n
George Provincial Hospital Secondary 49 49
Groote Schuur Hospital Tertiary 187 179
Mitchell’s Plain Hospital Secondary 28 27
New Somerset Hospital Secondary 45 42
Paarl Hospital Secondary 46 46
Victoria Hospital Secondary 12 10
Worcester Hospital Secondary 30 29
Table 2. Characteristics of the study population
Patients (N=382) Normotensive (N=184) Hypertensive (N=198) p-value
Age (years), mean (SD) 50 (16.1) 41.2 (14.3) 58.5 (12.9) <0.001
Gender male, n (%) 146 (38.2) 76 (41.3) 70 (35.4) 0.248
ASA status (N=379), n (%) <0.001
I 127 (33.5) 107 (59.1) 20 (10.1)
II 187 (49.3) 62 (34.3) 125 (63.1)
III 59 (15.6) 11 (6.1) 48 (24.2)
IV 6 (1.6) 1 (0.6) 5 (2.5)
Risk factors for hypertension, n (%)
BMI (N=358) 28.2 (7.2) 26.6 (6.8) 29.7 (7.3) <0.001
Smoking 160 (41.9) 89 (48.4) 71 (35.9) 0.778
Dyslipidaemia 48 (12.6) 7 (3.8) 41 (20.7) <0.001
NIDDM 19 (5.0) 5 (2.7) 14 (7.1) 0.060
IDDM 42 (11.0) 6 (3.3) 36 (18.2) <0.001
Men >55 years 55 (14.4) 18 (9.8) 37 (18.7) 0.014
Women >65 years 46 (12.0) 7 (3.8) 39 (19.7) <0.001
Target organ damage, n (%)
Left ventricular hypertrophy 39 (10.2) 4 (2.2) 35 (17.7) <0.001
Coronary artery disease 14 (3.7) 2 (1.1) 12 (6.1) 0.012
Heart failure 5 (1.3) 1 (0.5) 4 (2.0) 0.204
Chronic kidney disease 27 (10.4) 2 (2.0) 25 (15.7) <0.001
CVA/TIA 6 (1.6) 1 (0.5) 5 (2.5) 0.120
Peripheral arterial disease 8 (2.1) 2 (1.1) 6 (3.0) 0.185
Retinopathy 8 (2.1) 0 (0.0) 8 (4.0) 0.008
Other comorbid disease
COPD/asthma 36 (9.4) 13 (7.1) 23 (11.6) 0.161
HIV/AIDS 24 (6.3) 16 (8.7) 8 (4.0) 0.090
SD = standard deviation; ASA = American Society of Anesthesiologists; BMI = body mass index; NIDDM = non­insulin dependent diabetes mellitus; IDDM = insulin dependent diabetes 
mellitus; CVA = cerebrovascular accident; TIA = transient ischaemic attack; COPD = chronic obstructive pulmonary disease.
Table 3. Classification of the severity of hypertension* (N=198)
Hypertensive, n (%)
Normotensive 99 (50.0)
Grade 1: mild (SBP 140 ­ 159 or DBP 90 ­ 99 mmHg) 66 (33.3)
Grade 2: moderate (SBP 160 ­ 179 mmHg or DBP 100 ­ 109 mmHg) 21 (10.6)
Grade 3: severe (SBP ≥180 mmHg or DBP ≥110 mmHg) 12 (6.1)
SBP = systolic blood pressure; DBP = diastolic blood pressure.
*Classification of hypertension as per the 2014 South African Hypertension Practice Guideline.[2]
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Table 4 lists the most common antihypertensive therapies in the 
study population. Of the patients who presented for surgery with 
a diagnosis of hypertension, 39/157 reported treatment non­
compliance (24.8%, 95% CI 18.2 ­ 31.8) (Table 5). A third of patients 
(50/156) taking antihypertensive medication admitted to forgetting 




Five out of every ten patients presenting for elective surgery in the 
Western Cape are hypertensive. Of these, 20% are undiagnosed 
and 40% are inadequately controlled. This study suggests that the 
perioperative period may be an important opportunity to identify 
undiagnosed hypertension as well as improve the management of 
known hypertensive patients in SA.
Once a patient is diagnosed with hypertension, access to 
medication in the community is good, but patient compliance with 
therapy becomes the more important determinant of subsequent 
hypertensive control.
These data suggest that the perioperative period could supplement 
primary healthcare services, through perioperative screening, 
treatment initiation and referral. This needs to be coupled with an 
appropriate educational programme to ensure subsequent patient 
compliance with therapy on discharge. This dual­pronged approach 
to hypertension in surgical patients has the potential for a large public 
health benefit in SA.
Implications of the study
It is estimated that 3.5 billion adults, or 60% of the world’s population, is 
hypertensive.[17] In the African region, the prevalence of hypertension 
is estimated at 46% for adults aged ≥25 years. The number of adults 
with hypertension is predicted to increase by ~60% by 2025, with a 
disproportionately high prevalence in developing countries.[18]
In sub­Saharan Africa, despite the high burden imposed by 
communicable diseases, hypertension has emerged as a significant 
medical and public health problem and is regarded as one of 
the continent’s greatest health challenges after HIV/AIDS.[1] It is 
estimated that if the 10 ­ 20 million people who are believed to have 
hypertension in sub­Saharan Africa were treated effectively, about 
250 000 deaths could be prevented annually.[19]
According to the South African Hypertension Practice Guideline,[2] 
30.4% of the SA adult population has hypertension. This chronic 
disease is regarded as the single most prevalent cardiovascular risk 
factor and as a predominant contributor to cardiovascular disease­
related morbidity and mortality.[1] In the 2015 SA mortality statistics, 
cerebrovascular disease ranked third, accounting for 5.0% of national 
natural causes of death, heart disease ranked fifth, accounting for 
4.8%, and hypertension­related diseases ranked seventh, accounting 
for 4.2%.[20]
Although hypertension is not directly linked to poor perioperative 
outcomes, it is associated with long­term cardiovascular morbidity 
and mortality.[2] Treating hypertension improves long­term 
outcome. [13] This study suggests that perioperative evaluation of 
blood pressure has the potential to: (i) newly diagnose hypertension 
in 10% of all adult patients presenting for elective surgery; (ii) provide 
surveillance for the adequacy of management of hypertension in 
the community; and (iii) play an active role in the management of 
hypertension using predefined interventions[21] to improve both 
understanding and control of hypertension in as many as 50% of 
patients who present for all elective surgery.
The global volume of surgery, based on population statistics from 
2005 to 2013, estimates an average imputed surgical rate of 5 227 
per 100 000 population.[22] With a conservative estimate of 20  000 
elective, adult non­cardiac, non­obstetric surgical procedures per 
annum in the Western Cape (B M Biccard, unpublished data, June 
2018), as many as 2 000 (10%) new cases of hypertension could be 
diagnosed perioperatively. Furthermore, a total of 8 000 (40%) of 
these patients would require further therapy optimisation in the 
perioperative period. The population attributable risk associated 
with hypertension for stroke in South Africa is ~50%, while that 
for ischaemic heart disease is 40%.[21] Optimisation of hypertension 
could therefore prevent 125 strokes and 244 coronary events in this 
Table 4. Most common antihypertensive therapies used
Antihypertensive treatment n (%)
Diuretic 124/160 (77.5)
ACE­I/ARB 97/160 (60.6)
Beta blocker 61/160 (38.1)
Calcium channel blocker 46/160 (28.8)
Alpha blocker 6/160 (3.8)
Other 4/160 (2.5)
ACE­I = angiotensin­converting enzyme inhibitor; ARB = angiotensin receptor blocker.
Table 5. Incidence of and reasons for non-compliance with hypertensive therapy*
Hypertensive patients on 
treatment, n/total %; 95% CI
Compliant 117/156 75.0; 68.2 ­ 81.2
Non­compliant 39/156 25.0; 18.2 ­ 31.8
Standardised questions to elicit non­compliance
Do you ever forget to take your medicine? 50/156 32.1; 24.7 ­ 39.3
Are you careless at times about taking your medicine? 35/154 22.7; 16.1 ­ 29.3
When you feel better, do you sometimes stop taking your medicine? 20/155 12.9; 7.6 ­ 18.2
Sometimes if you feel worse when taking your medication, do you stop taking it? 20/155 12.9; 7.6 ­ 18.2
Reasons for non­compliance (N=39)
Health system 3/39 7.9; 0.0 ­ 16.5
Condition 8/39 21.1; 8.1 ­ 34.0
Patient 22/39 57.9; 42.2 ­ 73.4
Therapy 6/39 15.8; 4.2 ­ 27.3
Socioeconomic 5/39 13.2; 2.4 ­ 23.9
*Compliance with medical therapy was assessed using the Morisky Medication Adherence Questionnaire.[15,16]
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population annually, based on the prevalence of stroke and coronary 
heart disease in our population (2.5% and 6.1%, respectively).
Implications for SA
When considering national statistics, with an average imputed 
surgical rate of 5 227 per 100 000 population[23] and estimating that 
50% of all surgeries are for adults aged ≥18 years of age and older 
(2 614 per 100 000 population), as many as 261 (10%) per 100 000 
new cases of hypertension could be diagnosed perioperatively 
annually, and the opportunity will exist to optimise hypertensive 
treatment in up to 1 046 (40%) per 100 000 patients annually. This 
approach to perioperative hypertension therefore has the potential to 
prevent 16 strokes and 32 coronary events per 100 000 of the adult 
population in SA, annually.
Study strengths and limitations
This was a multicentre, prospective observational study of 
hypertension in the Western Cape. The fact that we were able to 
follow the SA hypertension guidelines in confirming the diagnosis of 
hypertension on the day prior to surgery in this study increases our 
confidence that our results reflect the true burden of hypertensive 
disease in preoperative surgical patients. We expect the data to be 
broadly generalisable across the Western Cape, and possibly across 
SA for patients from similar social circumstances.
It is possible that the prevalence of hypertension may be 
overestimated in this cohort. Although the evaluation of hypertension 
was made in elective surgical patients on the day preceding surgery, 
it is possible that some of the patients may have been anxious, and 
hence spuriously fulfilled the diagnostic criteria. Furthermore, this 
study excluded all emergency cases, so it was not possible to obtain a 
true prevalence of hypertension in patients presenting for all surgery. 
However, we would expect the prevalence of hypertension to be 
higher in patients presenting for emergency surgery, as they are more 
likely than the elective population to have comorbid disease.
Finally, the information related to compliance with medical 
therapy should be viewed with some caution, as it is based on a 
relatively small sample size.
Conclusions
We believe that in SA there is a significant potential for public health 
interventions in the perioperative period. In particular, we have 
demonstrated a unique diagnostic and therapeutic opportunity in 
patients with hypertension. Further research is needed into other 
comorbidities such as anaemia and diabetes, where similar potential 
benefits may apply.
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